We are so confident in the effectiveness of these products, that if you don't experience the amazing rejuvenating and anti-bacterial benefits for yourself simply return the products to us with your proof of purchase email within 35 days, for a full refund - no questions asked! That's right! We offer a 100% 'no-quibble' money-back guarantee.
Copper's antimicrobial properties have been known for more than five millennia. The ancient Egyptians used copper pipes to transport water to destroy parasites and other water-borne pathogens. Shipbuilders have used copper for thousands of years to keep algae from encrusting on the hulls of ships. French vintners have used a copper sulphate compound to fight fungus on grapevines for hundreds years. Today, copper has a myriad of uses as well. A recent study showed that copper door handles and taps kill 95% of superbugs in hospitals. Cupron's technology now makes it possible to use these powerful and wide ranging antimicrobial properties in new ways.
Cupron's technological breakthrough is based on the development of techniques to bond a copper oxide compound and other metallic compounds to a range of textile fibers. Cupron's manufacturing technology permanently binds its proprietary copper compound to textile fibers, non-woven fabrics, paper, latex and other polymeric products.
While highly sophisticated, implementation of this technology does not involve complicated or hazardous manufacturing methods. And best of all, the protection offered by Cupron-based products will last as long as the products themselves, regardless of multiple hot water washings, abrasion or bleach.
Silver Not Effective Says UK Report
The use of wound dressings containing silver by the National Health Service in England is a waste of money a new report there has found. The use of silver in coverings for wounds, ulcers and burns has grown steadily in recent years because it is generally thought to stop microbes from spreading. However, the Drug and Therapeutics Bulletin, which independently reviews evidence on drugs and treatments, recently said there was little evidence to support those claims.
According to media comments from the editor of the Bulletin, Ike Iheanacho,“few proper scientific trials have been carried out on the subject and the little research that exists was on small sample sizes, over inadequate periods of time and poorly conducted.”
Cupron Publication and supporting studies
Socks can reduce the risk of skin Pathologies for Diabetics
Cupron Emerging Technology for Treatment of Pedal Fungal and Bacterial Infections


